Stockreport

Cortexyme Expands Clinical Advisory Board With Key Clinical and Regulatory Experts

Cortexyme, Inc.  (CRTX) 
PDF SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modify [Read more]